P012 HOSPITAL RE-ADMISSION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE – WHAT ARE THE RISK FACTORS?
Rajan Patel(Whittington Hospital), Voishim Wong, William Blad(Whittington Hospital), Emma Routledge(Sheba Medical Center), Emma Johnson(University of Dundee), Saadiq Moledina(National Institute for Health and Care Research), Sina Jameie‐Oskooei(Sheba Medical Center), Renate Fromson(Sheba Medical Center)
Cited by 0
Related Papers
Anti-Müllerian Hormone Is a Marker of Gonadotoxicity in Pre- and Postpubertal Girls Treated for Cancer: A Prospective Study
|The Journal of Clinical Endocrinology & Metabolism|2012|202
Biomarkers in bronchiectasis
|European Respiratory Review|2024|31
Infantile choriocarcinoma treated with chemotherapy alone
|Medical and Pediatric Oncology|2003|18
Fibrinolysis during major abdominal surgery
|Fibrinolysis and Proteolysis|1990|15